Biopreparations for bee health

01Overview and value chain

Markers: [EC: EU Pollinators Initiative & Farm to Fork | OECD: Agricultural Biotechnology | Regulator: USDA-CVB/EPA (USA), EFSA (EU), MoA (China)]

Biopreparations for bee health are live-microbe, vaccine and botanical preparations that protect managed honeybees and bumblebees from American foulbrood, Nosema, viruses and the Varroa mite — the drivers of the record colony losses that threaten a U.S. crop-pollination market worth more than $15B a year. Dalan Animal Health’s American-foulbrood vaccine, the first honeybee vaccine to receive USDA conditional licensure (December 2022), primes the queen against Paenibacillus larvae and passes protection to her offspring through trans-generational immunity. On the probiotic side, Lactobacillus melliventris raised Bombus terrestris colony survival 2.5-fold with more than 10% more flowers visited, while Vita’s HiveAlive seaweed-and-thymol supplement delivered up to an 89% colony-population gain, 40% more honey and 57% fewer Nosema spores in independent trials. The category spans vaccines, probiotics, pathogen biocontrol and nutrition supplements.

The key directions of bee-health biopreparations are:

1. Honeybee vaccines (Honeybee Vaccines): prime the queen via trans-generational immune priming so her offspring resist Paenibacillus larvae (American foulbrood) — Dalan’s USDA-conditionally-licensed vaccine.
2. Probiotic and microbiome preparations (Bee Probiotic & Microbiome Preparations): native gut bacteria such as Lactobacillus melliventris and engineered yeast that colonize the bee gut and lift colony survival and pollination performance.
3. Pathogen biocontrol (Bee Pathogen Biocontrol): biological agents targeting Varroa, foulbrood and bee viruses (dsRNA/RNAi antivirals, entomopathogenic fungi).
4. Nutrition and immunity supplements (Bee Nutrition & Immunity Supplements): seaweed, thymol and propolis-based feed additives (Vita HiveAlive, Beeflow Max Poll) that boost gut health and cold tolerance.

Sectoral value chain

[pathogen/microbe isolation] ──> [strain/vaccine design] ──> [formulation] ──> [hive administration]
                                   │
                           (prime colony immunity)
                                   │
                                   ▼
[pollination service] <─── [colony monitoring] <─────┘

Value chain levels

Cross-cutting technologies of the sector:

• Trans-generational immune priming (Trans-Generational Immune Priming): vaccinating the queen so egg jelly conveys pathogen resistance to offspring — the mechanism behind Dalan’s foulbrood vaccine.
• Bee gut microbiome engineering (Bee Gut Microbiome Engineering): native and engineered bacteria/yeast (Lactobacillus, engineered Saccharomyces) that colonize the gut and deliver protection.
• dsRNA/RNAi antivirals (dsRNA/RNAi Antivirals): double-stranded RNA targeting bee viruses (Deformed Wing Virus) and Varroa, an emerging biocontrol class.

02US

The US anchors the category with the first honeybee vaccine and data-driven pollination-health services, against the backdrop of a >$15B pollination market and chronically high winter colony losses.

honeybee vaccine, pollination-health biotech, USDA-CVB licensure

• Dalan Animal Health: the first honeybee vaccine, targeting American foulbrood (Paenibacillus larvae), received USDA conditional licensure in December 2022; 2025 efficacy trials (also correlated with reduced Deformed Wing Virus) support a move to full licensure, targeted for the 2027 season, delivered to queens via candy to trigger trans-generational immunity.
• Beeflow: a pollination-biotech firm whose Max Poll supplement boosts bee immunity and cold tolerance so flights continue below 50°F; across 36 U.S. trials it delivered 18% more blueberry flower visits and a sevenfold rise in flights at suboptimal temperatures, operating across Chile, Peru, Mexico, Brazil and the U.S.
• USDA-CVB/EPA framing: the USDA Center for Veterinary Biologics licenses bee vaccines while the EPA registers hive-applied microbial and botanical treatments, together setting the U.S. route to market.

03CN

China, the world’s largest beekeeping and honey producer, pairs a propolis-and-royal-jelly industry with state-led bee-disease biocontrol research under the Ministry of Agriculture.

propolis/bee-product preparations, CAAS bee-disease biocontrol, MARA framework

• Hengliang Bee Industry (恒亮蜂业): a Zhejiang-Jiangshan bee-products firm producing propolis, royal jelly and hive-health preparations grounded in China’s propolis-rich traditional apitherapy, the basis for antimicrobial hive treatments.
• CAAS Bee Research Institute: the Chinese Academy of Agricultural Sciences’ bee-research arm systematizes bee-disease prevention and biocontrol — covering foulbrood, Varroa and sacbrood — and underpins China’s national bee-health guidance.
• MARA framework: microbial and botanical hive treatments register under the Ministry of Agriculture’s veterinary/biological-input track, framing the route to market for Chinese bee-health biopreparations.

04EU

The EU combines the leading bumblebee-biocontrol industry with science-led honeybee therapeutics, framed by the EU Pollinators Initiative and Farm to Fork.

bumblebee probiotics, seaweed/thymol supplements, EU Pollinators Initiative

• Biobest: a Belgian bumblebee and biological-control leader whose bee-microbiome work builds on Lactobacillus melliventris — a native bumblebee gut bacterium that lifted Bombus terrestris colony survival 2.5-fold and increased flowers visited by more than 10% in greenhouse trials.
• Vita Bee Health (UK): the HiveAlive feed supplement (Irish seaweed extracts, thymol, lemongrass oil and lecithin) delivered up to an 89% colony-population increase, 40% more honey, 57% fewer Nosema spores and 15% lower overwinter mortality in independent (Hellenic Institute of Apiculture) trials.
• EU Pollinators Initiative: the framework ties bee-health product uptake to pollinator-protection targets, while EFSA evaluates microbial and botanical hive treatments entering the EU market.

05Leading companies and research institutes

06Tech stack and innovations

The stack pairs immune-priming vaccines with gut-microbiome engineering and botanical/nutritional supplements.

1. Trans-generational immune-priming vaccines (Honeybee Immune-Priming Vaccines):
   • Dalan primes the queen against Paenibacillus larvae so worker jelly conveys resistance to eggs, the basis of the first USDA-conditionally-licensed honeybee vaccine.
   • The platform extends toward Deformed Wing Virus, with trial correlations showing reduced DWV in vaccinated colonies.
2. Probiotic and microbiome therapeutics (Bee Gut Microbiome Therapeutics):
   • Biobest’s Lactobacillus melliventris colonizes Bombus terrestris, persisting long-term and lifting survival 2.5-fold with more than 10% more flowers visited.
   • Engineered yeast (Saccharomyces) delivering dsRNA extends the microbiome route toward antiviral protection against bee viruses.
3. Botanical and nutritional supplements (Botanical & Nutritional Supplements):
   • Vita’s HiveAlive blends Irish seaweed extracts with thymol, lemongrass oil and lecithin to cut Nosema spores 57% and raise colony population up to 89% in independent trials.
   • Beeflow’s Max Poll feeds bees to lift immunity and cold tolerance, extending the pollination window below 50°F for an 18% gain in blueberry flower visits.

07Value chains and production pipelines

Industrial pipeline of a bee-health biopreparation (USDA-CVB / EPA / EFSA / MARA registration)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Pathogen/microbe       │ ───> │ 2. Strain/vaccine design  │
└───────────────────────────┘      └───────────────────────────┘
                                                  │
                                                  ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Hive administration    │ <─── │ 3. Formulation            │
└───────────────────────────┘      └───────────────────────────┘
               │
               ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Colony monitoring      │ ───> │ 6. Pollination service    │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Pathogen/microbe isolation

Bee pathogens (Paenibacillus larvae, Melissococcus plutonius, Nosema) and candidate gut probiotics (Lactobacillus, Bifidobacterium, Snodgrassella) are isolated from healthy and diseased colonies; the output is a panel of target pathogens and probiotic candidates.

Stage 2: Strain/vaccine design

A probiotic strain is selected or engineered (e.g. Lactobacillus melliventris, dsRNA-delivering yeast) or a vaccine antigen is mapped (Paenibacillus larvae antigen for trans-generational priming); the output is a vaccine or strain candidate.

Stage 3: Formulation

The candidate is stabilized as queen candy (vaccine), a liquid feed supplement or pollen patty (probiotic/seaweed-thymol blend), or a spray; Vita’s HiveAlive also stabilizes syrup for roughly five months, and the output is a hive-ready product.

Stage 4: Hive administration

The product is delivered to the queen (vaccine candy for trans-generational immunity), fed to the colony (probiotic or supplement), or applied topically; the output is a cohort of treated colonies.

Stage 5: Colony monitoring

Nosema spore load, overwinter survival and virus titres are tracked across the season — the 57% Nosema reduction and 15% lower overwinter mortality seen with HiveAlive exemplify the measurable outcomes; the output is a colony-health record.

Stage 6: Pollination service

Treated colonies are integrated into beekeeping integrated pest management and pollination operations — Beeflow’s 18% gain in blueberry visits closes the loop from hive health to pollination productivity, registered under USDA-CVB/EPA, EFSA or MARA frameworks.